000 | 01548nam a22002777a 4500 | ||
---|---|---|---|
020 | _a9781472410610 (Hardback) | ||
082 |
_a347.77 _bLEE |
||
100 | _aLee Joo-Young | ||
245 | _aHuman Rights Framework for Intellectual Property, Innovation and Access to Medicines | ||
260 |
_aNew York: _bRoutledge, _c2016. |
||
300 | _axii,287p. | ||
520 | _aThis book examines the relationship between intellectual property in pharmaceuticals and access to medicines from a human rights perspective, with a view to contributing to the development of a human rights framework that can guide States in enacting and implementing intellectual property law and policy. The study primarily explores whether conflicts between patents and human rights in the context of access to medicines are inevitable, or whether patents can be made to serve human rights. | ||
650 | _aHuman rights | ||
650 | _aRight to health | ||
650 | _aIntellectual property | ||
650 | _aHealth services accessibility - Law and legislation | ||
650 | _aMedical care - Law and legislation | ||
650 | _aPatient Rights | ||
650 | _aHealth Services Accessibility - legislation and jurisprudence | ||
650 | _aPublic health safeguards in the TRIPS agreement | ||
650 | _aHuman right to access to medicines | ||
650 | _aThe right to science and culture | ||
650 | _aRelationship between TRIPS and international human rights law in the context of access to medicines | ||
650 | _aHuman rights, intellectual property, innovation and access to medicines | ||
942 | _cBK | ||
999 |
_c344560 _d344560 |